ICD-10-CM Billable Code

C82.1A

Follicular lymphoma grade II, in remission

Clinical Classification Guidelines

Medical Intelligence & Overview

Follicular lymphoma is a type of blood cancer that originates in the lymphatic system, which is part of the body's immune defense. Specifically, follicular lymphoma affects the lymph nodes, causing them to swell and potentially impacting other parts of the body. When diagnosed as grade II, it indicates a moderate level of cell abnormality. The term 'in remission' refers to a state where signs and symptoms of the disease have significantly decreased or are no longer observable following treatment. This condition is classified under the ICD-10 code C82.1A, highlighting its specific subtype and remission status.

Causes & Symptoms

Clinical Causes: Genetic mutations within lymphocyte cells Age-related changes in the immune system Family history of lymphoma or other blood cancers Immunodeficiency conditions, such as HIV/AIDS Exposure to certain chemicals or chemicals in the environment Previous radiation therapy or chemotherapy

Key Symptoms: Painless swelling of lymph nodes, often in the neck, armpits, or groin Persistent fatigue or weakness Unexplained weight loss Fever that comes and goes Night sweats Feeling full after eating only a small amount Itching without a clear cause

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of medical history review, physical examinations, and various laboratory and imaging tests. A definitive diagnosis requires a tissue biopsy, where a sample of lymph node or other affected tissue is examined microscopically. The grading of follicular lymphoma, such as grade II, is determined by assessing how abnormal the cells look under the microscope. Additional tests may include blood tests, CT or PET scans to evaluate the spread of the disease, and bone marrow biopsies if necessary. Once diagnosed, the disease stage and remission status are assessed to guide treatment planning.

Treatment Protocols: Watchful waiting: Monitoring the disease without immediate treatment in cases where the lymphoma is slow-growing and not causing symptoms. Immunotherapy: Using medications that help the immune system target cancer cells. Chemotherapy: Employing drugs to destroy cancerous lymphoma cells. Radiation therapy: Using targeted radiation to eliminate lymphoma in specific areas. Targeted therapy: Drugs designed to interfere with specific molecules involved in tumor growth. Stem cell transplantation: In some cases, replacing diseased bone marrow with healthy cells after high-dose therapy.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C82.1A a billable ICD-10 code?
Yes, C82.1A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C82.1A?
Clinical documentation must specify the nature of Follicular lymphoma grade II, in remission and any associated comorbidities for accurate reporting.

Cite this Clinical Reference